Skip to Content

Tag: Respircardia

Also Noted

Sleep therapy system receives $58.5M in funding

December 19, 2017HME News Staff

MINNETONKA, Minn. - The makers of a transvenous implantable neurostimulation system for treating central sleep apnea have received $58.5 million in financing. The financing for Respicardia and its remed? System was led by ZOLL Medical Corp., a manufacturer of medical devices and related software solutions. "We believe the remed? System will soon become the treatment of choice for patients suffering from central sleep apnea," stated Bonnie Labosky, president and CEO of Respicardia. "Proceeds from...

Funding, Respircardia, Sleep Therapy

Read Full Articlered right arrow icon